Deltex Medical Group Plc

Deltex Medical (DEMG)

Buy
Sell
Company name:Deltex Medical Group Plc
Company Description:A group engaged in the manufacture and marketing of oesophageal Doppler haemodynamic monitoring systems
EPIC:DEMGTrading Currency:GBX
Market Sector:AIMPISIN:GB0059337583
Market Segment:ASX1Share Type:DE
WWW Address:http://www.deltexmedical.com/Description:ORD 1P
Industry Sector:HEALTH CARE EQUIPMENT & SERVICES
 Price Price Change [%] Bid Offer Open High Low Volume
 1.30 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 1.20 1.40 1.30 1.30 1.30 150,000
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 6.82 524.46 -0.00 -0.03 - - - 2.75 - 0.90

Deltex Medical Key Figures

(at previous day's close)
Market Cap.6.82m
Shares In Issue524.46m
Prev. Close1.30
PE Ratio- 
Dividend Yield-%
EPS - basic-0.03p
Dividend PS-p
Dividend Cover- 
Cash Flow PS0.12p
Return On Equity (ROE)-6.05%
Operating Margin-4.93%
PEG Factor- 
EPS Growth Rate90.00%
Dividends PS Growth Rate-%
Net Debt2.93m
Gross Gearing59.12%
Quick Assets2.16m
Net Working Capital0.69m
Intangibles / Fixed Assets77.58%
Turnover PS0.81p
Pre-Tax Profit PS-0.04p
Retained Profit PS-0.03p
Cash PS0.17p
Net Cash PS-0.28p
Net Tangible Asset Value PS *0.03p
Net Asset Value PS0.51p
Spread0.20 (14.29%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Deltex Medical Balance Sheet

LSE:DEMG:Liabilities+EQLSE:DEMG:Assets

Share Price Performance

Sample Period †HighLow
1 week1.331.30
4 weeks1.331.18
12 weeks1.401.18
1 year2.750.90

Share Price Chart (5 years)

Deltex Medical Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1.33-0.02-1.891.300.281.31
4 weeks1.30--1.180.291.30
12 weeks1.40-0.10-7.141.180.261.29
26 weeks1.60-0.30-18.751.180.311.37
1 year1.130.1815.560.900.771.58
3 years2.38-1.08-45.260.701.091.40
5 years4.13-2.83-68.480.700.771.78
† periods calculated are whole weeks rather than calendar months

Deltex Medical Key Management Ratios

Deltex Medical Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio24.30 
PE Ratio- 
Tobin's Q Ratio 1.05 
Tobin's Q Ratio (excl. intangibles)1.76 
Dividend Yield-%
Market-to-Book Ratio2.44 
Price-to-Pre-Tax Profit PS-32.47 
Price-to-Retained Profit PS-40.34 
Price-to-Cash Flow PS11.20 
Price-to-Sales PS1.60 
Price-to-Net Tangible Asset Value PS1,704.51 
Price-to-Cash PS7.51 
Net Working Capital PS0.13 
Price Pct to Working Capital PS9.85%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Deltex Medical Financial Ratios

(Leverage Ratios)
Debt Ratio35.39%
Debt-to-Equity Ratio0.55 
Debt-to-Equity Ratio (excl. Intgbl)363.50 
Debt-to-Equity Market Value0.21 
Net Gearing45.14%
Net Gearing (excl. Intangibles)76.27%
Gross Gearing59.12%
Gross Gearing (excl. Intangibles)99.90%
Gearing Under 1 Year36.74%
Gearing Under 1 Year (excl. Intgbl)62.07%
Assets/Equity2.45 
Cash/Equity34.20 
(Liquidity Ratios)
Net Working Capital to Total Assets10.65%
Current Ratio1.29 
Quick Ratio (Acid Test)0.91 
Liquidity Ratio0.38 
Cash & Equiv/Current Assets29.50%
(Solvency Ratios)
Enterprise Value7.23m
CFO/Sales0.14 
CFO/Attributable Profit- 
CFO/Assets0.09 
CFO/Debt0.16 
Total Debt/Equity Market Value0.56 
Total Debt/Sales0.90 
Total Debt/Pre-Tax Profit-18.29 
Total Debt3.84m
Total Debt/Net Current Assets5.55%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-65.00%
5 yr Compound Earnings Growth-54.86%
10 yr Compound Earnings Growth-30.25%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)
-0.0011-0.0001

Deltex Medical Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-5.11%
Return On Assets (ROA)-2.61%
Net Profit Margin-3.97%
Assets Turnover0.66 
Return On Equity (ROE)-6.05%
Return On Investment (ROI)-4.21%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-3.97%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.59 
Fixed Assets Turnover1.23 
Current Assets Turnover1.42 
Net Working Capital Turnover 
Inventory Turnover5.34 
(Other Operating Ratios)
Total Assets-to-Sales1.52 
Debtors-to-Sales30.85%
Debt Collection Period112.60Days

Deltex Medical Dividends

Sorry No Data Available

Deltex Medical Fundamentals
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
turnover5.46100.00%4.94100.00%4.96100.00%4.26100.00%m
pre tax profit-2.52-46.13%-2.10-42.56%-1.34-27.00%-0.21-4.93%m
attributable profit-2.14-39.15%-2.14-43.25%-1.27-25.59%-0.17-3.97%m
retained profit-2.14-39.15%-2.14-43.25%-1.27-25.59%-0.17-3.97%m
eps - basic (p)-0.90 -0.70 -0.30 -0.03 
eps - diluted (p)-0.90 -0.70 -0.30 -0.03 
dividends per share- - - - 

Deltex Medical Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
LSE:DEMG:Liabilities+EQLSE:DEMG:AssetsLSE:DEMG:Liabilities+EQLSE:DEMG:AssetsLSE:DEMG:Liabilities+EQLSE:DEMG:AssetsLSE:DEMG:Liabilities+EQLSE:DEMG:Assets
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
ASSETS
fixed assets fixed assets0.436.36%0.274.66%0.599.10%0.406.08%m
intangibles intangibles2.4035.37%2.4942.30%2.5339.20%2.6540.82%m
fixed investments fixed investments--%--%0.406.20%0.375.71%m
current assets - other current assets - other--%--%0.192.95%0.111.74%m
stocks stocks0.7611.22%0.7512.83%0.6810.54%0.9214.09%m
debtors debtors2.6138.46%2.1436.48%1.4823.01%1.1417.58%m
cash & securities cash & securities0.588.59%0.223.73%0.588.99%0.9113.98%m
TOTAL6.78100%5.88100%6.45100%6.50100%m
LIABILITIES
creditors - short creditors - short3.2748.30%3.4658.84%2.5439.32%2.3936.74%m
creditors - long creditors - long1.0916.03%1.1219.04%1.5023.27%1.4522.39%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL4.3664.32%4.5877.88%4.0462.60%3.8459.12%m
EQUITY
ord cap, reserves ord cap, reserves2.5938.15%1.4524.62%2.5539.59%2.7943.02%m
prefs, minorities prefs, minorities-0.17-2.48%-0.15-2.50%-0.14-2.19%-0.14-2.14%m
TOTAL2.4235.68%1.3022.12%2.4137.40%2.6640.88%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Deltex Medical Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF-1.82-0.93-1.320.61m
Pre-Financing CF-2.37-1.22-1.530.41m
Retained CF-0.05-0.350.350.34m

Deltex Medical Brokers

NameActivityTypeMnemonicCode
Arden Partners PlcMarket Maker(MMF)Broker/DealerARDAARRRGB2100A
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MMF)Broker/DealerCANAHOARGB21001
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Liberum Capital LimitedMarket Maker(MMF)Broker/DealerLIBCLCAPGB21
Piper Jaffray LtdMarket Maker(MMF)Broker/DealerPIPRPIPRGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
LSE
DEMG
Deltex Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201205 10:37:49